1887

Abstract

Summary

Epstein—Barr virus (EBV), an agent with growth transforming potential for human B cells, is associated with certain B cell lymphomas in man and also with an epithelial tumour, undifferentiated nasopharyngeal carcinoma (NPC). Since B cell growth transformation is associated with the constitutive expression of a small number of EBV-coded latent proteins, the nuclear antigens EBNA 1, EBNA 2, EBNA 3 and EBNA-LP and the latent membrane protein (LMP), the present work sought to determine whether this same pattern of virus gene expression occurred in NPC. Tumour biopsies were taken from NPC patients from three areas of differing tumour incidence (Kenya, Algeria, Britain) and immediately snap-frozen, as were biopsies of non-EBV-related carcinomas for controls. Immunoblotting of PAGE-separated proteins with selected human sera identified 24 NPC biopsies clearly expressing EBNA 1. When the analysis was extended using selected human sera with antibodies against the other EBNAs, there was no detectable expression of EBNA 2, EBNA 3 or EBNA-LP in any of these 24 biopsies; their EBNA 2-negative status was confirmed using a monoclonal antibody (MAb) PE2 which was reactive in immunoblotting and in immunoprecipitation with EBNA 2A and EBNA 2B proteins. Similar experiments with two different LMP-specific MAbs, CS1 to 4 and S12, revealed heterogeneity between NPC biopsies; 9/24 biopsies were demonstrably LMP-positive, the degree of expression varying considerably between individual tumours in a manner which was not related to the level of EBNA 1 expression. None of the 24 NPC biopsies expressed detectable amounts of EBV lytic cycle antigens. A nude mouse-passaged NPC cell line, C15, likewise expressed EBNA 1 and LMP but none of the other EBV latent proteins nor lytic cycle antigens. This work identifies a novel type of EBV-cell interaction in NPC cells which is distinct from that seen in transformed B cell lines and from that seen to date in EBV-positive B cell lymphomas.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-69-5-1051
1988-05-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/69/5/JV0690051051.html?itemId=/content/journal/jgv/10.1099/0022-1317-69-5-1051&mimeType=html&fmt=ahah

References

  1. BAER R., BANKIER A. T., BIGGIN M. D., DEININGER P. L., FARRELL P. J., GIBSON T. J., HATFUIX G., HUDSON G. S., SATCHWELL S. C, SéGUIN C, TUFFNELL P. S., BARRELL B. G. 1984; DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature, London 310:207–211
    [Google Scholar]
  2. BORNKAMM G. W., HUDEWITZ J., FREESE U. K., ZIMBER U. 1982; Deletion of the non-transforming EBV strain P3HR-1 causes fusion of the large internal repeat to the DSL region. Journal of Virology 43:952–968
    [Google Scholar]
  3. BRICHACEK B., HIRSCH I., SIBL O., VILLKUSOVA E., VONKA V. 1983; Association of some supraglottic laryngeal carcinomas with EB vims. International Journal of Cancer 32:193–197
    [Google Scholar]
  4. BRICHACEK B., HIRSCH I., SIBL O., VILIKUSOVA E., VONKA V. 1984; Presence of Epstein-Barr virus DNA in carcinomas of the palatine tonsil. Journal of the National Cancer Institute 72:809–815
    [Google Scholar]
  5. BUSSON P., GANEM G., FLORES P., MUGNERET F., CAILLOU B., BRAHAM K., WAKASUGI H., LIPINSKI M., TURSZ T. 1988; Establishment and characterization of three nude mouse-transplantable EBV-containing nasopharyngeal carcinoma tumours. International Journal of Cancer in press
    [Google Scholar]
  6. CLEARY M. L., DORFMAN R. F., SKLAR J. 1986 Failure in immunological control of the virus infection: post-transplant lymphomas. The Epstein-Barr Virus: Recent Advances163–181 Edited by Epstein M. A., Achong B. G. London: Heinemann;
    [Google Scholar]
  7. CLIFFORD P. 1972; Carcinogens in the nose and throat: nasopharyngeal carcinoma in Kenya. Proceedings of the Royal Society of Medicine 65:682–686
    [Google Scholar]
  8. DAMBAUGH T., HENNESSY K., CHAMNANKIT L., KLEFF E. 1984; U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proceedings of the National Academy of Sciences, U.S.A 81:7632–7636
    [Google Scholar]
  9. DAMBAUGH T., HENNESSY K., FENNEWALD S., KLEFF E. 1986 The virus genome and its expression in latent infection. The Epstein-Barr Virus: Recent Advances13–45 Edited by Epstein M. A., Achong B. G. London: Heinemann;
    [Google Scholar]
  10. DE THé G. 1982 Epidemiology of Epstein-Barr virus and associated diseases in man. The Herpesviruses 125–103 Edited by Roizman B. New York & London: Plenum Press;
    [Google Scholar]
  11. DILLNER K., KALLIN B., ALEXANDER H., ERNBERG I., UNO M., ONO Y., KLEIN G., LERNER R. L. 1986; An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA-5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines. Proceedings of the National Academy of Sciences, U.S.A 83:6641–6646
    [Google Scholar]
  12. EPSTEIN M. A., ACHONG B. G. 1979 Relationship of the virus to Burkitt’s lymphoma. The Epstein-Barr Virus321–337 Edited by Epstein M. A., Achong B. G. Wien & New York: Springer Verlag;
    [Google Scholar]
  13. FAHRAEUS R., HU L. F., ERNBERG L, FINKE J., ROWE M., KLEIN G., FALK K., NILSSON E., YADAF M., BUSSON P., TURSZ T., KALLIN B. 1988; Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. International Journal of Cancer in press
    [Google Scholar]
  14. GREENSPAN J. S., GREENSPAN D., LENNETTE E. T., ABRAMS D. I., CONANT M. A., PETERSEN V., FREESE U. K. 1985; Replication of Epstein-Barr virus within the epithelial cells of oral ‘hairy’ leukoplakia, an AIDS-associated lesion. New England Journal of Medicine 313:1564–1571
    [Google Scholar]
  15. GREGORY C. D., KIRCHGENS C, EDWARDS C F., YOUNG L. S., ROWE M., FORSTER A., RABBITTS T. H., RICKINSON A. B. 1987; Epstein-Barr virus-transformed human precursor B cell lines: altered growth phenotype of lines with germlike or rearranged but non-expressed heavy chain genes. European Journal of Immunology 17:1199–1207
    [Google Scholar]
  16. HENLE W., HENLE G. 1976; Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. International Journal of Cancer 17:1–7
    [Google Scholar]
  17. HENLE W., HO J. H. C, HENLE G., CHAN J. C. W., KWAN H. C. 1977; Nasopharyngeal carcinoma: significance of changes in Epstein-Barr virus-related antibody patterns following therapy. Internationaljournal of Cancer 20:663–672
    [Google Scholar]
  18. HENNESSY K., FENNEWALD S., HUMMEL M., COLE T., KEIFF E. 1984; A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection. Proceedings of the National Academy of Sciences, U.S.A 81:7207–7211
    [Google Scholar]
  19. HENNESSY K., WANG F., WOODLAND BUSHMAN E., KEIFF E. 1986; Definitive identification of a member of the Epstein-Barr virus nuclear protein 3 family. Proceedings of the National Academy of Sciences, U.S.A 83:5693–5697
    [Google Scholar]
  20. HUANG D. P., HO J. H., HENLE W., HENLE G. 1974; Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies. International Journal of Cancer 14:580–588
    [Google Scholar]
  21. KALLIN B., DILLNER J., ENRBERG I., EHLIN-HENRIKSSON B., ROSSEN A., HENLE W., HENLE G., KLEIN G. 1986; Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells. Proceedings of the National Academy of Sciences, U.S.A 83:1499–1503
    [Google Scholar]
  22. KLEIN G., GIOVANELLA B. C, LINDAHL T., FIALKOW P. J., SINGH S., STEHLIN J. S. 1974; Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proceedings of the National Academy of Sciences, U.S.A 71:4737–4741
    [Google Scholar]
  23. LENOIR G. M., VUILLAUME M., BONNARDEL C. 1985 Use of lymphomatous and lymphoblastoid cells lines in the study of Burkitt’s lymphoma. Burkitt’s Lymphoma: A Human Cancer Model309–318 Edited by Lenoir G. M., O’Connor G., Olweny C. L. M. Lyon: IARC Scientific Publication No. 60;
    [Google Scholar]
  24. LEYVRAZ S., HENLE W., CHAHINIAN A. P., PERLMANN C, KLEIN G., GORDON R. E., ROSENBLUM M., HOLLAND J. F. 1985; Association of Epstein-Barr virus with thymic carcinoma. New England Journal of Medicine 312:1296–1299
    [Google Scholar]
  25. LEIBOWITZ D., KOPAN R., FUCHS E., SAMPLE I., KIEFF E. 1987; An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes. Molecular and Cellular Biology 7:2299–2308
    [Google Scholar]
  26. MANN K. P., STAUNTON D., THORLEY-LAWSON D. A. 1985; Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells. Journal of Virology 55:710–720
    [Google Scholar]
  27. MUIR C. S. 1972 Nasopharyngeal carcinoma in non-Chinese populations. Oncogenesis and Herpesviruses367–371 Edited by Biggs P. M., de Thé G., Payne L. N. Lyon: IARC Scientific Publications No. 2;
    [Google Scholar]
  28. NONOYAMA M., HUANG C. H., PAGANO J. S., KLEIN G., SINGH S. 1973; DNA of Epstein-Barr virus detected in tissue of Burkitt’s lymphoma and nasopharyngeal carcinoma. Proceedings of the National Academy of Sciences, U.S.A 70:3265–3268
    [Google Scholar]
  29. OLD L. J., CLIFFORD P., BOYSE E. A., DE HARVEN E., GEERING G., OETTGEN H. F., WILLIAMSON B. 1966; Precipitating antibody in human serum to an antigen present in cultured Burkitt’s lymphoma cells. Proceedings of the National Academy of Sciences, U.S.A 56:1699–1704
    [Google Scholar]
  30. PEARSON G. R., VROMAN B., CHASE B., SCULLEY T., HUMMEL M., KIEFF E. 1983; Identification of polypeptide components of the Epstein-Barr virus early antigen complex using monoclonal antibodies. Journal of Virology 4:1193–201
    [Google Scholar]
  31. RAAB-TRAUB N., FLYNN K. 1986; The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883–889
    [Google Scholar]
  32. RAAB-TRAUB N., HOOD R., YANG C-S., HENRY B., PAGANO J. S. 1983; Epstein-Barr virus transcription in nasopharyngeal carcinoma. Journal of Virology 48:580–590
    [Google Scholar]
  33. RHODES G., RUMPOLD H., KURKI P., PATRICK K. M., CARSON D. A., VAUGHAN J. H. 1987; Autoantibodies in infectious mononucleosis have specificity for the glycine-alanine repeating region of the Epstein-Barr virus nuclear antigen. Journal of Experimental Medicine 165:1026–1040
    [Google Scholar]
  34. RICKINSON A. B., YOUNG L. S., ROWE M. 1987; Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. Joural of Virology 61:1310–1317
    [Google Scholar]
  35. ROWE D., FARRELL P. J., MILLER G. 1987; Novel nuclear antigens recognized by human sera in lymphocytes latently infected by Epstein-Barr virus. Virology 156:153–162
    [Google Scholar]
  36. ROWE M., ROWE D. T., GREGORY C. D., YOUNG L. S., FARRELL P. J., RUPANI H., RICKINSON A. B. 1987a; Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt’s lymphoma cells. EMBO Journal 6:2743–2751
    [Google Scholar]
  37. ROWE M., EVANS H. S., YOUNG L. S., HENNESSY K., KIEFF E., RICKINSON A. B. 1987b; Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. Journal of General Virology 68:1575–1586
    [Google Scholar]
  38. SAEMUNDSEN A. K., ALBECK H., HANSEN J. P. H., NIELSEN N. H., ANVRET M., HENLE W., HENLE G., THOMSEN K. A., KRISTENSEN H. K., KLEIN G. 1982; Epstein-Barr virus nasopharyngeal and salivary gland carcinomas in Greenland Eskimoes. British Journal of Cancer 46:721–728
    [Google Scholar]
  39. SIXBEY J. W., VESTERINEN E. H., NEDRUD J. G., RAAB-TRAUB N., WALTON L. A., PAGANO J. S. 1983; Replication of Epstein-Barr virus in human epithelial cells infected in vitro. Nature, London 306:480–483
    [Google Scholar]
  40. SIXBEY J. W., NEDRUD J. G., RAAB-TRAUB N., HANES R. A., PAGANO J. S. 1984; Epstein-Barr virus replication in oropharyngeal epithelial cells. New England Journal of Medicine 310:1225–1230
    [Google Scholar]
  41. SIXBEY J. W., DAVIS D. S., YOUNG L. S., HUTT-FLETCHER L., TEDDER T. F., RICKINSON A. B. 1987; Human epithelial cell expression of an Epstein-Barr virus receptor. Journal of General Virology 68:805–811
    [Google Scholar]
  42. SUMMERS W. P., GROGAN E. A., SHEDD D., ROBERT M., LIU C-R., MILLER G. 1982; Stable expression in mouse cells of nuclear neoantigen after transfer of a 3-4 megadalton cloned fragment of Epstein-Barr virus DNA. Proceedings of the National Academy of Sciences, U.S.A 79:5688–5692
    [Google Scholar]
  43. TRUMPER P. A., EPSTEIN M. A., GIOVANELLA B. C., FINERTY S. 1977; Isolation of infectious EB virus from the epithelial tumour cells of nasopharyngeal carcinoma. International Journal of Cancer 20:655–662
    [Google Scholar]
  44. TUGWOOD J. D., LAU W-H., O S-K., TSAO S-Y., MARTIN W. M. C, SHIU W., DESGRANGES C, JONES P. H., ARRAND I. R. 1987; Epstein-Barr virus-specific transcription in normal and malignant nasopharyngeal biopsies and in lymphocytes from healthy donors and infectious mononucleosis patients. Journal of General Virology 68:1081–1091
    [Google Scholar]
  45. WANG D., LEIBOWITZ D., KIEFF E. 1985; An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831–840
    [Google Scholar]
  46. WANG F., PETTI L., BRAUN D., SEUNG S., KIEFF E. 1987; A bicistronic Epstein-Barr virus mRNA encodes two nuclear proteins in latently infected growth transformed lymphocytes. Journal of Virology 61:945–954
    [Google Scholar]
  47. WATERHOUSE I., MUIR C, SHANMUGARATNAM K., POWELL J. 1982 Cancer Incidence in Five Continents IV Lyon: IARC Scientific Publications; No. 42
    [Google Scholar]
  48. WOLF H., ZUR HAUSEN H., BECKER V. 1973; EB viral genome in epithelial nasopharyngeal carcinoma cells. Nature New Biology 244:245–247
    [Google Scholar]
  49. YOUNG L. S., CLARK D., SIXBEY J. W., RICKINSON A. B. 1986; Epstein-Barr virus receptors on human pharnygeal epithelia. Lancet i:240–242
    [Google Scholar]
  50. YOUNG L. S., YAO Q. Y., ROONEY C M., SCULLEY T. B., MOSS D. J., RUPANI H., LAUX G., BORNKAMM G. W., RICKINSON A. B. 1987; New type B isolates of Epstein-Barr virus from Burkitt’s lymphoma and from normal individuals in endemic areas. Journal of General Virology 68:2853–2862
    [Google Scholar]
  51. ZENG Y. 1985; Seroepidemiological studies on nasopharyngeal carcinoma in China. Advances in Cancer Research 44:121–138
    [Google Scholar]
  52. ZUR HAUSEN H., SCHULTE-HOLTHAUZEN H., KLEIN G., HENLE G., HENLE W., CLIFFORD P., SANTESSON L. 1970; EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature, London 228:1956–1958
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-69-5-1051
Loading
/content/journal/jgv/10.1099/0022-1317-69-5-1051
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error